Boston Scientific (BSX) Net Cash Flow Growth (3y) (2012 - 2026)
Boston Scientific (BSX) Net Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.80 Bn | 176.50 Bn | 6.27 Bn | -32.51% |
| 2 | Stryker | 128.84 Bn | 125.96 Bn | 3.81 Bn | -87.87% |
| 3 | Medtronic | 108.59 Bn | 99.37 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 68.51 Bn | 67.06 Bn | 3.61 Bn | -11.49% |
| 5 | Edwards Lifesciences | 48.18 Bn | 44.51 Bn | 1.29 Bn | -87.88% |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | 129.29% |
| 7 | GE HealthCare Technologies | 28.16 Bn | 25.88 Bn | 1.98 Bn | -65.12% |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.66 Bn | 21.54 Bn | 2.07 Bn | -48.90% |
| 10 | Steris | 21.46 Bn | 21.02 Bn | 697.10 Mn | 33.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.49% |
| Dec 31, 2025 | 2.24% |
| Sep 30, 2025 | 152.10% |
| Jun 30, 2025 | -39.71% |
| Mar 31, 2025 | 29.41% |
| Dec 31, 2024 | -510.91% |
| Sep 30, 2024 | 17.19% |
| Jun 30, 2024 | -4.26% |
| Mar 31, 2024 | 77.25% |
| Dec 31, 2023 | 34.86% |
| Sep 30, 2023 | 24.95% |
| Jun 30, 2023 | -28.17% |
| Mar 31, 2023 | -76.78% |
| Dec 31, 2022 | 113.38% |
| Sep 30, 2022 | 26.44% |
| Jun 30, 2022 | 2.86% |
| Mar 31, 2022 | -40.82% |
| Dec 31, 2021 | 27.23% |
| Sep 30, 2021 | -319.08% |
| Jun 30, 2021 | 80.07% |